Variant report
Variant | esv3422017 |
---|---|
Chromosome Location | chr19:41384512-41387760 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:20)
- CpG islands (count:184)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:20 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr19:41386211-41386665 | K562 | blood: | n/a | n/a |
2 | CTCF | chr19:41386288-41386587 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CTCF | chr19:41386284-41386617 | K562 | blood: | n/a | n/a |
4 | CTCF | chr19:41386312-41386552 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | CTCF | chr19:41387561-41387588 | LNCaP | prostate: | n/a | n/a |
6 | CTCF | chr19:41386384-41386566 | K562 | blood: | n/a | n/a |
7 | CTCF | chr19:41386320-41386470 | HEK293 | kidney: | n/a | n/a |
8 | CTCF | chr19:41386233-41386588 | H1-hESC | embryonic stem cell: | n/a | n/a |
9 | CTCF | chr19:41386434-41386449 | K562 | blood: | n/a | n/a |
10 | CTCF | chr19:41386301-41386581 | K562 | blood: | n/a | n/a |
11 | GATA2 | chr19:41387355-41387455 | SH-SY5Y | brain: | n/a | chr19:41387370-41387377 chr19:41387370-41387380 chr19:41387368-41387378 chr19:41387370-41387377 chr19:41387368-41387377 chr19:41387370-41387377 |
12 | MAX | chr19:41386259-41386608 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | POLR2A | chr19:41386273-41386431 | H1-hESC | embryonic stem cell: | n/a | n/a |
14 | POLR2A | chr19:41386101-41386269 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | POLR2A | chr19:41386159-41386584 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | RAD21 | chr19:41386294-41386634 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | RAD21 | chr19:41386302-41386499 | K562 | blood: | n/a | n/a |
18 | RAD21 | chr19:41386373-41386596 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | RAD21 | chr19:41386283-41386608 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | ZNF263 | chr19:41384603-41384719 | HEK293-T-REx | kidney: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:41386507-41386557 | HL-60 | blood: | n/a |
2 | chr19:41386507-41386557 | HL-60 | blood: | n/a |
3 | chr19:41386507-41386557 | MCF10A-Er-Src | breast: | n/a |
4 | chr19:41386507-41386557 | SAEC | small airway: | n/a |
5 | chr19:41386507-41386557 | BE2_C | brain: | n/a |
6 | chr19:41386507-41386557 | HRCEpiC | kidney: | n/a |
7 | chr19:41386441-41386491 | H1-hESC | embryonic stem cell: | embryo |
8 | chr19:41385865-41385915 | NHDF-neo | bronchial: | n/a |
9 | chr19:41385865-41385915 | NT2-D1 | testis: | n/a |
10 | chr19:41385865-41385915 | HUVEC | blood vessel: | n/a |
11 | chr19:41386507-41386557 | NH-A | brain: | n/a |
12 | chr19:41386507-41386557 | NHDF-neo | bronchial: | n/a |
13 | chr19:41386507-41386557 | ProgFib | skin: | n/a |
14 | chr19:41386441-41386491 | SK-N-SH_RA | brain: | n/a |
15 | chr19:41385865-41385915 | T-47D | breast: | n/a |
16 | chr19:41385865-41385915 | AG09319 | gingival: | n/a |
17 | chr19:41386507-41386557 | SK-N-SH | brain: | n/a |
18 | chr19:41386441-41386491 | AG09319 | gingival: | n/a |
19 | chr19:41385865-41385915 | SK-N-SH_RA | brain: | n/a |
20 | chr19:41385865-41385915 | PrEC | prostate: | n/a |
21 | chr19:41386441-41386491 | GM12891 | blood: | n/a |
22 | chr19:41386507-41386557 | LNCaP | prostate: | n/a |
23 | chr19:41385865-41385915 | HCT-116 | colon: | n/a |
24 | chr19:41385865-41385915 | Hepatocyte | liver: | n/a |
25 | chr19:41386507-41386557 | SK-N-MC | brain: | n/a |
26 | chr19:41386441-41386491 | T-47D | breast: | n/a |
27 | chr19:41385865-41385915 | ProgFib | skin: | n/a |
28 | chr19:41386507-41386557 | HRPEpiC | eye: | n/a |
29 | chr19:41385865-41385915 | H1-hESC | embryonic stem cell: | embryo |
30 | chr19:41386441-41386491 | HNPCEpiC | eye: | n/a |
31 | chr19:41385865-41385915 | AG04450 | lung: | fetal |
32 | chr19:41385865-41385915 | AoSMC | blood vessel: | n/a |
33 | chr19:41386507-41386557 | PrEC | prostate: | n/a |
34 | chr19:41386441-41386491 | AG04450 | lung: | fetal |
35 | chr19:41386507-41386557 | HMEC | breast: | n/a |
36 | chr19:41386441-41386491 | U87 | brain: | n/a |
37 | chr19:41386441-41386491 | GM12878 | blood: | n/a |
38 | chr19:41386507-41386557 | HepG2 | liver: | n/a |
39 | chr19:41385865-41385915 | HCM | heart: | n/a |
40 | chr19:41385865-41385915 | AG10803 | skin: | n/a |
41 | chr19:41386507-41386557 | MCF-7 | breast: | n/a |
42 | chr19:41386441-41386491 | HRE | kidney: | n/a |
43 | chr19:41385865-41385915 | HMEC | breast: | n/a |
44 | chr19:41386507-41386557 | SK-N-SH_RA | brain: | n/a |
45 | chr19:41386441-41386491 | HEEpiC | esophagus: | n/a |
46 | chr19:41385865-41385915 | GM12878 | blood: | n/a |
47 | chr19:41386507-41386557 | Jurkat | blood: | n/a |
48 | chr19:41385865-41385915 | ECC-1 | luminal epithelium: | n/a |
49 | chr19:41386441-41386491 | A549 | lung: | n/a |
50 | chr19:41385865-41385915 | RPTEC | kidney: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CYP2A7 | TF binding region |
CYP2A7 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546871198 | chr19:41384521-41384522 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113986398 | chr19:41384533-41384534 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535417801 | chr19:41384542-41384543 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs144617542 | chr19:41384569-41384570 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568938238 | chr19:41384577-41384578 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4453619 | chr19:41384578-41384579 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs147884612 | chr19:41384589-41384590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553233666 | chr19:41384630-41384631 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs4079367 | chr19:41384637-41384638 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs191003934 | chr19:41384644-41384645 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs372855525 | chr19:41384647-41384648 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs369173002 | chr19:41384648-41384649 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs575296850 | chr19:41384659-41384660 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs140346884 | chr19:41384668-41384669 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs564470109 | chr19:41384673-41384674 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs4079366 | chr19:41384675-41384676 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs540089737 | chr19:41384676-41384677 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs141169022 | chr19:41384686-41384687 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs372835097 | chr19:41384689-41384690 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs534092727 | chr19:41384691-41384692 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs186817628 | chr19:41384692-41384693 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs117539170 | chr19:41384702-41384703 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs374712130 | chr19:41384724-41384725 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568874033 | chr19:41384743-41384744 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs140403519 | chr19:41384760-41384761 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs369508713 | chr19:41384764-41384765 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551444191 | chr19:41384769-41384770 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs112946838 | chr19:41384781-41384782 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs191637615 | chr19:41384786-41384787 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146496348 | chr19:41384798-41384799 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs373269963 | chr19:41384811-41384812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149073318 | chr19:41384821-41384822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140997835 | chr19:41384822-41384823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535758188 | chr19:41384838-41384839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145739973 | chr19:41384841-41384842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370478567 | chr19:41384871-41384872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375259444 | chr19:41384883-41384884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368143024 | chr19:41384885-41384886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575591454 | chr19:41384914-41384915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183421221 | chr19:41384956-41384957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs375655919 | chr19:41384967-41384968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs538519437 | chr19:41385030-41385031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573277855 | chr19:41385031-41385032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs2431407 | chr19:41385061-41385062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs12981337 | chr19:41385115-41385116 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs4803389 | chr19:41385132-41385133 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs529154733 | chr19:41385183-41385184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544511938 | chr19:41385187-41385188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562809201 | chr19:41385201-41385202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532923946 | chr19:41385223-41385224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21364760 | CNVD |
Invasive pancreatic ductal carcinoma | 18765526 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Genital abnormality | 22378287 | CNVD |
Hypospadia | 22378287 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Astrocytoma | 22246337 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:41382600-41386200 | Weak transcription | Lung | lung |
2 | chr19:41383200-41387000 | Weak transcription | Liver | Liver |
3 | chr19:41384400-41384800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr19:41385600-41386000 | Weak transcription | Ovary | ovary |
5 | chr19:41386000-41386200 | Enhancers | Ovary | ovary |
6 | chr19:41386200-41386400 | Bivalent/Poised TSS | HUES64 Cell Line | embryonic stem cell |
7 | chr19:41386200-41386600 | Bivalent/Poised TSS | H1 Cell Line | embryonic stem cell |
8 | chr19:41386200-41386600 | Enhancers | Lung | lung |
9 | chr19:41386200-41386600 | Flanking Active TSS | Ovary | ovary |
10 | chr19:41386400-41386600 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
11 | chr19:41386400-41386600 | Enhancers | Adipose Nuclei | Adipose |
12 | chr19:41386400-41386600 | Bivalent Enhancer | Fetal Intestine Small | intestine |
13 | chr19:41386400-41386600 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
14 | chr19:41386400-41387000 | Bivalent Enhancer | Fetal Intestine Large | intestine |
15 | chr19:41386600-41387800 | Weak transcription | Lung | lung |
16 | chr19:41386800-41387000 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
17 | chr19:41387000-41387200 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
18 | chr19:41387000-41388400 | Enhancers | Fetal Intestine Large | intestine |
19 | chr19:41387000-41389800 | Enhancers | Liver | Liver |